PMS2 and cancer: This cancer type is strongly linked with MMRd due to somatic or germline mutations in MLH1, MSH2, MSH6, PMS2, and MLH1 promoter hypermethylation, and enhanced levels of MMRd-associated mutational signatures (e.g., SBS6).